Second-generation perfluorocarbon emulsion blood substitutes

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 28, Issue 1, 2000, Pages 25-38

  Lowe, Kenneth C ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD; CELLS; CHEMILUMINESCENCE; EMULSIONS; MOLECULAR DYNAMICS; ORGANIC COMPOUNDS; RESPIRATORY MECHANICS; SURFACE ACTIVE AGENTS; TISSUE;

MONOCARBAMATE; OSTWALD RIPENING; PERFLUOROCARBON; POLYMORPHONUCLEAR LEUCOCYTES; RESPIRATORY GAS CARRYING BLOOD SUBSTITUTE;

BLOOD SUBSTITUTES;

ANTICOAGULANT AGENT; BLOOD SUBSTITUTE; FLUOROCARBON; LUMINOL; PERFLUORODECALIN; PHORBOL 13 ACETATE 12 MYRISTATE; PHOSPHATIDYLCHOLINE;

BLOOD SUBSTITUTION; CHEMOLUMINESCENCE; EMULSION; INFLAMMATION; ISCHEMIA; LUNG GAS EXCHANGE; NEUTROPHIL; REVIEW; THROMBOCYTE AGGREGATION INHIBITION;

EID: 0033976030     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731190009119783     Document Type: Review

References (38)

1. Lowe, K.C. Perfluorochemicals in vascular medicine. Vasc. Med. Rev, 5, 15-32 (1994).
2. Zuck, T.F. and Riess, J.G. Current status of injectable oxygen carriers. Crit. Rev. Clin. Lab. Sci. 31, 295-324 (1994).
3. Spence, R.K. Perfluorocarbons. In Principles of Transfusion Medicine, 2nd edn., Rossi, E.C., Simon, T.L., Moss, G.S. and Gould, S.A. (Eds.), pp. 189-196. Baltimore, Williams and Watkins, 1996.
4. Lowe, K.C. Perfluorochemical respiratory gas carriers: applications in medicine and biotechnology. Science Prog. 80, 169-193 (1997).
5. Riess, J.G. and Krafft, M.P. Advanced fluorocarbon-based systems for oxygen and drug delivery, and diagnosis. Art. Cells, Blood Subs., Immob. Biotechnol. 25, 43-52 (1997).
6. Gervits, L.L. Perfluorocarbon-based blood substitutes. Russian experience. In Fluorine in Medicine in the 21st Century, Banks, R.E. and Lowe, K.C. (Eds.), pp. 197-205. Shrewsbury, Rapra, 1994.
7. Riess, J.G. Reassessment of criteria for the selection of perfluorochemicals for second-generation blood substitutes. Analysis of structure/property relationships. Art. Org. 8, 44-56 (1984).
8. Kaufman, R.J. Clinical development of perfluorocarbon-based emulsions as blood substitutes. In Blood Substitutes, Physiological Basis of Efficacy, Winslow, R.M., Vandegriff, K.D. and Intaglietta, M. (Eds.), pp. 53-75. Boston, Birkhäuser, 1995.
9. Ohyanagi, H. Perfluorochemical emulsions as blood substitutes: clinical data and new applications. In Artificial Red Cells. Materials, Performances and Clinical Study as Blood Substitutes, Tsuchida, E. (Ed.), pp. 199-226. Chichester John Wiley, 1995,
10. Moore R.E. and Clark, L.C. Synthesis and physical properties of perfluorocompounds useful as synthetic blood candidates. In Oxygen Carrying Colloidal Blood Substitutes, Frey, R., Beisbarth, H. and Stosseck, K. (Eds.), pp. 50-60. Munich, Zuckschwerdt, 1982.
11. Moore, G.G.I., Koenig, T.A., Flynn, R.M., Guerra, M.A., Schulz, J.F., Costello, M.G., Kaufman, R.J., Richard, T.A. and Goodin, T. H-or Cl-perfluoroethers as blood substitutes. Proc. 15th Int. Symp. Fluorine Chemistry, Vancouver, p. 133, August 1997.
12. Kabalnov, A., Weers, J.G., Arlauskas, R. and Tarara, T. Phospholipids as emulsion stabilizers. I. Interfacial tensions, Langmuir 11, 2966-2974 (1995).
13. Sharma, S.K., Lowe, K.C. and Davis, S.S. Novel compositions of emulsified perfluorochemicals for biological uses. In Blood Substitutes, Chang, T.M.S. and Geyer, R.P. (Eds.), pp. 447-450. New York, Marcel Dekker, 1989.
14. Mattrey, R.F. The potential role of perfluorochemicals (PFCs) in diagnostic imaging. Art. Cells, Blood Subs., Immob. Biotechnol. 22, 295-313 (1994).
15. Flaim, S.F. (1997) Perflubron-based emulsion: efficacy as temporary oxygen carrier. In Advances in Blood Substitutes. Industrial Opportunities and Medical Challenges, Winslow, R.M., Vandegriff, K.D. and Intaglietta, M. (Eds.), pp. 91-132. Boston, Birkhäuser, 1997.
16. Weers, J.G. A physico-chemical evaluation of perfluorochemicals for oxygen transport applications. J. Fluorine Chem. 64, 73-93 (1993).
17. Mukerji, B. and Sloviter, H.A. A stable perfluorochemical blood substitute. Transfusion 31, 24-326 (1991).
18. Bollands, A.D., Lowe, K.C., Sharma, S.K. and Davis, S.S. Biocompatibility studies with a novel perfluorochemical emulsion. In Blood Substitutes, Chang, T.M.S. and Geyer, R.P. (Eds.), pp. 451-453. New York, Marcel Dekker, 1989.
19. Johnson, O.L., Washington, C. and Davis, S.S. Long-term stability studies of fluorocarbon oxygen transport emulsions. Int. J. Pharm. 63, 65-72 (1990).
20. Bentley, P.K., Johnson, O.L., Washington, C. and Lowe, K.C. Uptake of concentrated perfluorochemical emulsions into rat lymphoid tissues. J. Pharm. Pharmac. 45, 182-185 (1993).
21. Edwards, C.M., Lowe, K.C., Röhlke, W., Geister, U., Reuter, P. and Meinert, H. Effects of a novel perfluorocarbon emulsion on neutrophil chemiluminescence in human whole blood in vitro. Art. Cells, Blood Subs., Immob. Biotechnol. 25, 255-260 (1997).
22. Meinert, H., Fackler, R., Knoblich, A., Mader, J., Reuter, P. and Röhlke, W. On the perfluorocarbon emulsions of second generation. Art. Cells, Blood Subs., Immob. Biotechnol. 20, 95-113 (1992).
23. Forman, M.B., Ingram, D.A. and Murray, J.J. Attenuation of myocardial reperfusion injury by perfluorochemical emulsions. Clin. Hemorheol. 12, 121-140 (1992).
24. Forman, M.B., Pitarys, C.J., Vildibill, H.D., Lambert, T.L., Ingram, D.A., Virmani, R. and Murray, J.J. Pharmacologic perturbation of neutrophils by Fluosol results in a sustained reduction in infarct size in the canine model of reperfusion. J. Am. Coll. Cardiol. 19 205-216 (1992).
25. Smith, T.M., Steinhorn, D.M., Thusu, K., Fuhrman, B.P. and Dandona, P.A. A liquid perfluorochemical decreases the in vitro production of reactive oxygen species by alveolar macrophages. Crit. Care Med. 231, 533-1539 (1995).
26. Rossman, J.E., Caty, M.G., Rich, G.A., Karamanoukian, H.L. and Azizkhan, R.G. Neutrophil activation and chemotaxis after in vitro treatment with perfluorocarbon. J. Pediat. Surg. 8, 1147-1151 (1996).
27. Castagna, M., Takai, Y., Kaibuchi, K., Sano, K., Kikkawa, U. and Nishizuka, Y. Direct activation of calcium activated, phospholipid-dependent protein kinases by tumour-promoting phorbol esters. J. Biol. Chem. 257, 7847-7851 (1982).
28. Lowe, K.C. Emulsified perfluorochemicals for oxygen transport to tissues: effects on lymphoid system and immunological competence. In Oxygen Transport to Tissue, Vol. X, Mochizuki, M., Honig, C.R., Koyama, T., Goldstick, T.K. and Bruley, D.F. (Eds.), pp. 655-663. New York, Plenum, 1988.
29. Riess, J.G. and Le Blanc, M. Preparation of perfluorochemicals emulsions for biomedical use: principles, materials and methods. In Blood Substitutes: Preparation, Physiology and Medical Applications, Lowe, K.C. (Ed.), pp. 94-129. Chichester, Ellis Horwood, 1988.
30. Riess, J.G. and Greiner, J. Perfluoroalkylated sugar derivatives as surfactants and co-surfactants for biomedical uses. In Carbohydrates as Organic Raw Materials, Descotes, G. (Ed.), pp. 209-259. Weinheim, VCH Verlagsgesellschaft, 1993.
31. Kissa, E. (Ed.) Fluorinated Surfactants. Synthesis, Properties, Applications. New York, Marcel Dekker, 1994.
32. Riess, J.G. Highly fluorinated systems for oxygen transport, diagnosis and drug delivery. Colloids Surfaces A 84, 33-48 (1994).
33. Jouani, M.A., Szonyi, F., Trabelsi, H. and Cambon, A. Synthèse de tensioactifs non ioniques F-alkylés polyhydroxylés. Bull. Soc. Chim. Fr. 131, 173-176 (1994).
34. Edwards, C.M., Lowe, K.C., Trabelsi, H., Lucas, P. and Cambon, A. Novel fluorinated surfactants for perfluorochemical emulsification: biocompatibility assessments of glycosidic and polyol derivatives. Art. Cells, Blood Subs., Immob. Biotechnol. 25, 327-333 (1997).
35. Armstrong, J.K., Meiselman, H.J. and Fisher, T.C. Inhibition of red blood cell-induced platelet aggregation in whole blood by a nonionic surfactant, poloxamer 188 (RheothRx® Injection). Thromb. Res. 79, 437-450 (1995).
36. Edwards, C.M., May, J.A., Heptinstall, S. and Lowe, K.C. Effects of Pluronic® F-68 (Poloxamer 188) on platelet aggregation in human whole blood. Thromb. Res. 81, 511-512 (1996).
37. Edwards, C.M., Heptinstall, S. and Lowe, K.C. Effects of the copolymer surfactant, Pluronic® F-68, on platelet aggregation in human whole blood. Art. Cells, Blood Subs., Immob. Biotechnol. 25, 493-499 (1997).
38. Schaer, G.L., Hursey, T.L., Abrahams, S.L., Buddemeier, K., Ennis, B., Rodriguez, R., Hubbell, J.P., Moy, J. and Parrillo, J.E. Reduction in reperfusion-induced myocardial injury in dogs by RheothRx® Injection (Poloxamer 188 N.F.), a hemorheological agent that alters neutrophil function. Circulation 90, 2964-2975 (1994).